Doppler assessment of the pulsatility index of the middle cerebral artery during constriction of the fetal ductus arteriosus after indomethacin therapy.
To investigate the effects of constriction of the ductus arteriosus on the pulsatility index of the middle cerebral artery, maximum velocity waveforms were obtained in 13 fetuses (one set of twins) whose mothers were treated with indomethacin for preterm labor (n = 9) or polyhydramnios (n = 3). Eleven of the fetuses manifested ductal constriction within 48 hours of therapy, whereas two fetuses had constriction after 1 week of therapy. Six of the 13 fetuses also manifested tricuspid insufficiency in association with constriction of the ductus arteriosus. All abnormal cardiac changes resolved in utero after discontinuation of indomethacin. No difference in the pulsatility index values of the middle cerebral artery was observed in the fetuses with ductal constriction but without tricuspid regurgitation (n = 7) when the values were compared with those obtained in absence of ductal constriction (1.87 +/- 0.37 vs. 1.88 +/- 0.33). In the fetuses that manifested both ductal constriction and tricuspid insufficiency (n = 6), the pulsatility index values in the middle cerebral artery were significantly lower in the presence of ductal constriction when compared with the values obtained in the absence of ductal constriction (2.22 +/- 0.26 vs. 1.57 +/- 0.34). These results indicate that a response to indomethacin sufficient to cause both ductal constriction and tricuspid insufficiency decreases the pulsatility index of the middle cerebral artery.
Mari
G
G
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030.
Moise
K J
KJ
Deter
R L
RL
Kirshon
B
B
Huhta
J C
JC
Carpenter
R J
RJ
Cotton
D B
DB
D001775:Blood Circulation / Q000187:drug effects; D002536:Cerebral Arteries / Q000187:drug effects / Q000196:embryology / Q000502:physiology*; D004373:Ductus Arteriosus / Q000187:drug effects / Q000503:physiopathology*; D005260:Female; D005333:Fetus / Q000098:blood supply* / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D011247:Pregnancy; D011673:Pulsatile Flow / Q000187:drug effects / Q000502:physiology*; D012212:Rheology; D014463:Ultrasonography; D014661:Vasoconstriction / Q000187:drug effects*
D007213:Indomethacin